Drug Type Biological products |
Synonyms AT02 Amylon Therapeutics |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Amylon Therapeutics BVStartup |
Active Organization Amylon Therapeutics BVStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Spinal Muscular Atrophy | Preclinical | NL | Amylon Therapeutics BVStartup | - |